STOCK TITAN

[Form 3] ROCKWELL MEDICAL, INC. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Heather Hunter, Senior Vice President and Chief Operating Officer of Rockwell Medical, Inc. (RMTI), reported ownership of 138,259 shares of common stock and several option and restricted stock unit grants. The filing lists non-qualified stock options exercisable through 09/09/2032, 03/17/2033, 03/14/2034, and 05/20/2035 with exercise prices of $1.66, $1.37, $1.39, and $1.07, respectively. The report notes RSUs vesting in 2026 and 2027 and discloses the Form 3 was filed late for administrative reasons.

Heather Hunter, Vicepresidente Senior e Direttore Operativo di Rockwell Medical, Inc. (RMTI), ha comunicato la proprietà di 138.259 azioni ordinarie e diverse assegnazioni di opzioni e unità azionarie vincolate. La dichiarazione elenca opzioni di acquisto azioni non qualificate esercitabili fino al 09/09/2032, 03/17/2033, 03/14/2034 e 05/20/2035 con prezzi di esercizio di $1.66, $1.37, $1.39 e $1.07, rispettivamente. Il rapporto segnala RSU che maturano nel 2026 e 2027 e indica che il Form 3 è stato presentato in ritardo per motivi amministrativi.

Heather Hunter, Vicepresidenta Senior y Directora Ejecutiva de Operaciones de Rockwell Medical, Inc. (RMTI), informó la propiedad de 138,259 acciones ordinarias y varias adjudicaciones de opciones y unidades de acciones restringidas. La presentación lista opciones de compra de acciones no calificadas exercitables hasta 09/09/2032, 03/17/2033, 03/14/2034 y 05/20/2035 con precios de ejercicio de $1.66, $1.37, $1.39 y $1.07, respectivamente. El informe señala RSUs que vencen en 2026 y 2027 y divulga que el Formulario 3 fue presentado tarde por motivos administrativos.

Heather HunterRockwell Medical, Inc. (RMTI)의 수석 부사장 겸 최고 운영 책임자로서 138,259 주의 보통주 및 여러 옵션 및 제한 주식 단위 보조금을 소유한 것으로 보고했습니다. 제출서는 비적격 주식 옵션이 09/09/2032, 03/17/2033, 03/14/203405/20/2035까지 행사 가능하며 행사가는 $1.66, $1.37, $1.39$1.07로 명시되어 있습니다. 보고서는 RSU가 20262027에 vesting되며, Form 3의 제출이 행정 사유로 지연되었다고 밝힙니다.

Heather Hunter, Vice-présidente principale et Directrice des opérations de Rockwell Medical, Inc. (RMTI), a déclaré posséder 138 259 actions ordinaires et plusieurs attributions d’options et d’unités d’actions restreintes. Le dossier indique des options d’achat d’actions non qualifiées exerçables jusqu’aux 09/09/2032, 03/17/2033, 03/14/2034 et 05/20/2035 avec des prix d’exercice de $1.66, $1.37, $1.39 et $1.07, respectivement. Le rapport mentionne des RSU qui vestent en 2026 et 2027 et indique que le Formulaire 3 a été déposé tardivement pour des raisons administratives.

Heather Hunter, Senior Vice President und Chief Operating Officer von Rockwell Medical, Inc. (RMTI), meldete Eigentum an 138.259 Stammaktien sowie mehrere Optionen und Restricted Stock Unit-Zuwendungen. Die Anmeldung listet nicht qualifizierte Aktienoptionen, die bis 09/09/2032, 03/17/2033, 03/14/2034, und 05/20/2035 ausübbar sind, mit Ausübungspreisen von $1.66, $1.37, $1.39 und $1.07, respectively. Der Bericht erwähnt RSUs, die in 2026 und 2027 vesten, und gibt an, dass das Formular 3 aus administrativen Gründen verspätet eingereicht wurde.

Heather Hunter، نائبة الرئيس الأولى ومدير العمليات التنفيذي في Rockwell Medical, Inc. (RMTI)، أعلنت عن امتلاكها 138,259 سهماً عادياً وعدة من منح الخيارات ووحدات الأسهم المقيدة. تقرّ الملاحظة بأن الأوامر غير المؤهلة لشراء الأسهم قابلة للممارسة حتى 09/09/2032، 03/17/2033، 03/14/2034 و05/20/2035 بأسعار ممارسة $1.66، $1.37، $1.39 و$1.07 على التوالي. يشير التقرير إلى vesting لـ RSUs في 2026 و2027 ويكشف أن النموذج 3 قد تم تقديمه متأخراً لأسباب إدارية.

Heather Hunter,Rockwell Medical, Inc.(RMTI)的资深副总裁兼首席运营官,报告持有138,259股普通股以及若干期权和受限股票单位的授予。该披露显示可在09/09/203203/17/203303/14/203405/20/2035 行使的非合格股票期权,行权价分别为 $1.66$1.37$1.39$1.07。报告还提到 RSUs 将于 20262027 归属,并披露 Form 3 因行政原因提交延迟。

Positive
  • Direct ownership of 138,259 shares provides meaningful insider alignment
  • RSUs totalling 107,220 (22,220 + 85,000) vest across 20262027, linking pay to continued service
  • Multiple option grants with exercise prices between $1.07 and $1.66 incentivize long‑term retention
Negative
  • Form 3 was filed late due to administrative delays, which can temporarily reduce transparency

Insights

Insider ownership and standard executive awards, with a late initial filing noted.

The reporting shows direct ownership of 138,259 common shares plus multiple non-qualified stock option grants and restricted stock units that vest over multi-year schedules, aligning compensation with continued service.

These equity awards create deferred incentives tied to tenure; key dates include RSU vesting on 03/14/2026, 03/14/2027, and 05/20/2027, and option exercise windows through 05/20/2035. The late filing was attributed to administrative delays.

Heather Hunter, Vicepresidente Senior e Direttore Operativo di Rockwell Medical, Inc. (RMTI), ha comunicato la proprietà di 138.259 azioni ordinarie e diverse assegnazioni di opzioni e unità azionarie vincolate. La dichiarazione elenca opzioni di acquisto azioni non qualificate esercitabili fino al 09/09/2032, 03/17/2033, 03/14/2034 e 05/20/2035 con prezzi di esercizio di $1.66, $1.37, $1.39 e $1.07, rispettivamente. Il rapporto segnala RSU che maturano nel 2026 e 2027 e indica che il Form 3 è stato presentato in ritardo per motivi amministrativi.

Heather Hunter, Vicepresidenta Senior y Directora Ejecutiva de Operaciones de Rockwell Medical, Inc. (RMTI), informó la propiedad de 138,259 acciones ordinarias y varias adjudicaciones de opciones y unidades de acciones restringidas. La presentación lista opciones de compra de acciones no calificadas exercitables hasta 09/09/2032, 03/17/2033, 03/14/2034 y 05/20/2035 con precios de ejercicio de $1.66, $1.37, $1.39 y $1.07, respectivamente. El informe señala RSUs que vencen en 2026 y 2027 y divulga que el Formulario 3 fue presentado tarde por motivos administrativos.

Heather HunterRockwell Medical, Inc. (RMTI)의 수석 부사장 겸 최고 운영 책임자로서 138,259 주의 보통주 및 여러 옵션 및 제한 주식 단위 보조금을 소유한 것으로 보고했습니다. 제출서는 비적격 주식 옵션이 09/09/2032, 03/17/2033, 03/14/203405/20/2035까지 행사 가능하며 행사가는 $1.66, $1.37, $1.39$1.07로 명시되어 있습니다. 보고서는 RSU가 20262027에 vesting되며, Form 3의 제출이 행정 사유로 지연되었다고 밝힙니다.

Heather Hunter, Vice-présidente principale et Directrice des opérations de Rockwell Medical, Inc. (RMTI), a déclaré posséder 138 259 actions ordinaires et plusieurs attributions d’options et d’unités d’actions restreintes. Le dossier indique des options d’achat d’actions non qualifiées exerçables jusqu’aux 09/09/2032, 03/17/2033, 03/14/2034 et 05/20/2035 avec des prix d’exercice de $1.66, $1.37, $1.39 et $1.07, respectivement. Le rapport mentionne des RSU qui vestent en 2026 et 2027 et indique que le Formulaire 3 a été déposé tardivement pour des raisons administratives.

Heather Hunter, Senior Vice President und Chief Operating Officer von Rockwell Medical, Inc. (RMTI), meldete Eigentum an 138.259 Stammaktien sowie mehrere Optionen und Restricted Stock Unit-Zuwendungen. Die Anmeldung listet nicht qualifizierte Aktienoptionen, die bis 09/09/2032, 03/17/2033, 03/14/2034, und 05/20/2035 ausübbar sind, mit Ausübungspreisen von $1.66, $1.37, $1.39 und $1.07, respectively. Der Bericht erwähnt RSUs, die in 2026 und 2027 vesten, und gibt an, dass das Formular 3 aus administrativen Gründen verspätet eingereicht wurde.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Hunter Heather

(Last) (First) (Middle)
C/O ROCKWELL MEDICAL, INC.
30142 WIXOM ROAD

(Street)
WIXOM MI 48393

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/23/2025
3. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Operating Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 138,259(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Options (2) 09/09/2032 Common Stock 60,000 $1.66 D
Non-Qualified Stock Options (3) 03/17/2033 Common Stock 32,990 $1.37 D
Non-Qualified Stock Options (4) 03/14/2034 Common Stock 47,190 $1.39 D
Non-Qualified Stock Options (5) 05/20/2035 Common Stock 170,000 $1.07 D
Explanation of Responses:
1. Includes 22,220 restricted stock units ("RSUs"), which will vest in two equal installments on March 14, 2026 and March 14, 2027, subject to the Reporting Person's continued service to the Issuer, and 85,000 RSUs, which will vest in full on May 20, 2027, subject to the Reporting Person's continued service to the Issuer.
2. Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued service to the Issuer.
3. Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer.
4. Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 14, 2028, subject to the Reporting Person's continued service to the Issuer.
5. Stock options vest 1/3 on the first anniversary of May 20, 2025, with the remainder vesting in equal monthly installments through May 20, 2028, subject to the Reporting Person's continued service to the Issuer.
Remarks:
Ex. 24 - Power of Attorney. This Form 3 is being filed late due to administrative delays in obtaining the Reporting Person's EDGAR codes.
/s/ Megan Timmins, Attorney-in-Fact for Heather Hunter 10/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares does Heather Hunter report owning in RMTI?

The filing reports 138,259 shares of common stock owned directly by Heather Hunter.

What restricted stock units (RSUs) does Heather Hunter have?

The report discloses 22,220 RSUs vesting in two equal installments on 03/14/2026 and 03/14/2027, and 85,000 RSUs vesting in full on 05/20/2027.

What stock options are listed in the Form 3 for Heather Hunter?

Non-qualified stock options exercisable on 09/09/2032 ($1.66), 03/17/2033 ($1.37), 03/14/2034 ($1.39), and 05/20/2035 ($1.07) are reported.

Why was the Form 3 filed late?

The filing states it was filed late due to administrative delays in obtaining the reporting person's EDGAR codes.

What is Heather Hunter's role at Rockwell Medical?

She is reported as Senior Vice President and Chief Operating Officer and is listed as an officer on the Form 3.
Rockwell Med Inc

NASDAQ:RMTI

RMTI Rankings

RMTI Latest News

RMTI Latest SEC Filings

RMTI Stock Data

40.97M
29.37M
13.71%
17.19%
2.97%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
WIXOM